Loss of P16INK4 expression is frequent in high grade gliomas.

@article{Nishikawa1995LossOP,
  title={Loss of P16INK4 expression is frequent in high grade gliomas.},
  author={Ryo Nishikawa and Frank B Furnari and H M Lin and Wadih Arap and Mitchel S. Berger and Webster K Cavenee and H J Su Huang},
  journal={Cancer research},
  year={1995},
  volume={55 9},
  pages={1941-5}
}
P16INK4 is a cell cycle regulator that specifically binds to and inactivates cyclin-dependent kinase 4 (CDK4). Its encoding gene (p16/CDKN2) maps to chromosome 9p21, a region that undergoes frequent loss of heterozygosity in a variety of human tumors. We have analyzed the p16/CDKN2 gene and its expression in a series of primary glioma samples. Although homozygous deletion or mutation of the p16/CDKN2 gene was uncommon in this series and P16INK4 protein was detectable in all grade II tumors, it… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.

Neuropathology : official journal of the Japanese Society of Neuropathology • 2015
View 1 Excerpt

The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis.

International journal of clinical and experimental medicine • 2015
View 1 Excerpt

Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2009
View 3 Excerpts

Similar Papers

Loading similar papers…